SHANGHAI, Feb. 23, 2025 /PRNewswire/ — On February 15, 2025, Sanyou Bio conducted a full review of its Intelligent Super-trillion Molecule Discovery Platform. As the core technology of the platform, the intelligent super-trillion molecule library boasts […]
Poster presentation of preliminary data from the Phase 2a investigator-initiated study UCORIS in ulcerative colitis (UC) at the 20th ECCO Congress UC is a chronic inflammatory bowel disease that causes inflammation and ulcers (sores) in […]
Poster presentation of preliminary data from the Phase 2a investigator-initiated study UCORIS in ulcerative colitis (UC) at the 20th ECCO Congress UC is a chronic inflammatory bowel disease that causes inflammation and ulcers (sores) in […]
HONG KONG, Feb. 20, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) today announced the company has successfully enrolled the first patient in its multicenter, randomized, double-blind Phase III clinical trial of ivonescimab in […]
RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2025 /PRNewswire/ — Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced the activation of its first clinical trial site […]